查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495344

等温核酸扩增技术 (INAAT) 市场：2024-2033 年全球产业分析、规模、占有率、成长、趋势、预测

Isothermal Nucleic Acid Amplification Technology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 342 Pages | 商品交期: 2-5个工作天内

价格
简介目录

持久性市场研究对等温核酸扩增技术 (INAAT) 市场进行了详细分析，提供了对其复杂动态和未来发展轨蹟的见解。从市场趋势到成长催化剂、抑制剂和新兴模式，我们提供 2024 年至 2033 年有价值的统计数据和预测。

关键见解

  • INAAT 市场规模（2024 年）：52.6 亿美元
  • 市场预测（2033 年）：145.6 亿美元
  • 全球市场成长率（2024-2033 年复合年增长率）：12.0%

INAAT 市场 - 报告范围：

INAAT 市场涵盖医疗保健、製药和生物技术等行业的各种应用。 INAAT广泛用于快速、准确的核酸检测，对于疾病诊断、病原体检测和基因检测至关重要。该市场服务于广泛的最终用户，包括医院、诊断实验室、研究机构和生物製药公司，并提供具有多种临床和研究应用的高度通用的技术。市场成长是由技术进步、对即时诊断的需求不断增加以及传染病流行等因素所推动的。

市场驱动因素：

全球 INAAT 市场受到几个关键成长动力的支持。分子诊断技术的进步将提高 INAAT 的效率和应用，并促进其在各行业的采用。此外，对现场诊断的需求不断增长，尤其是在新兴国家，对 INAAT 作为快速、准确疾病检测的关键技术产生了巨大的需求。此外，人们越来越重视传染病的早期和准确诊断，这促使了研发活动的增加以及新型 INAAT 平台和检测方法的开发。

市场限制因素：

儘管 INAAT 市场成长前景广阔，但仍面临监管合规、替代技术竞争和高成本等课题。诊断技术的严格监管要求给製造商和最终用户带来了合规负担，影响了市场扩张。此外，来自PCR等其他核酸扩增技术的竞争对INAAT的广泛使用提出了课题。此外，与 INAAT 平台和试剂相关的高成本可能会影响市场成长，因此需要开发具有成本效益的解决方案。

市场机会：

INAAT 市场透过技术创新、产业联盟和市场多元化提供了利润丰厚的成长机会。个人化医疗、传染病流行和基因研究进展等新趋势正在促使製造商探索 INAAT 在临床和研究环境中的新用途和配方。此外，透过策略合作伙伴关係、研究合作和併购，市场参与者正在扩大其产品组合，增强其技术能力，并加强其在关键地区的市场占有率。此外，增加研发投资以及政府加强对创新和医疗基础设施的支持正在创造一个有利于市场扩张和多元化的环境。

本报告涵盖的主要问题

  • 推动 INAAT 市场全球成长的关键因素是什么？
  • 技术进步和产业趋势如何影响 INAAT 应用和配方的演变？
  • INAAT 产业的市场参与者面临哪些主要课题和机会？
  • 哪些产业和地区对 INAAT 製造商来说最具成长潜力？
  • 领先公司正在采取哪些策略来使其 INAAT 产品脱颖而出并在竞争格局中获得市场占有率？

目录

第 1 章执行摘要

第二章市场概述

  • 市场范围/分类
  • 市场定义/范围/限制

第三章市场背景

  • 市场动态
  • 情境预测
  • 机会图分析
  • 投资可行性矩阵
  • PESTLE 和 Porter 分析
  • 监理状况
  • 区域母公司市场前景

第四章全球等温核酸扩增技术（INAAT）市场分析

  • 过去的市场规模价值（金额）分析，2019-2023 年
  • 2024-2033 年当前及未来市场规模价值（金额）预测
    • 年成长趋势分析
    • 绝对利润机会分析

第五章全球等温核酸扩增技术 (INAAT) 市场分析：依产品

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023 年
  • 2024-2033 年当前与未来市场规模（金额）分析与预测
    • 设备
    • 试剂
  • 2019-2023 年年成长趋势分析
  • 2024-2033 年绝对获利机会分析

第六章全球等温核酸扩增技术 (INAAT) 市场分析：依技术分类

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023 年
  • 2024-2033 年当前与未来市场规模（金额）分析与预测
    • NASBA
    • 哈德
    • 灯
    • SDA
    • SPIA
    • 近
    • TMA
    • RCA
    • 机器人流程自动化
    • SMAP2
    • 其他
  • 2019-2023 年年成长趋势分析
  • 2024-2033 年绝对获利机会分析

第 7 章全球等温核酸扩增技术 (INAAT) 市场分析：依应用分类

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023 年
  • 2024-2033 年当前与未来市场规模（金额）分析与预测
    • 验血
    • 传染病诊断
    • 癌症
    • 其他
  • 2019-2023 年年成长趋势分析
  • 2024-2033 年绝对获利机会分析

第 8 章全球等温核酸扩增技术 (INAAT) 市场分析：依最终用途划分

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023 年
  • 2024-2033 年当前与未来市场规模（金额）分析与预测
    • 医院
    • 中心实验室与参考实验室
    • 其他
  • 2019-2023 年年成长趋势分析
  • 2024-2033 年绝对获利机会分析

第九章全球等温核酸扩增技术 (INAAT) 市场依地区分析

  • 简介
  • 过去的市场规模（金额）分析，2019-2023 年
  • 目前市场规模（金额）分析与预测，2024-2033 年
    • 北美
    • 拉丁美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 区域市场吸引力分析

第十章北美等温核酸扩增技术（INAAT）市场分析（依国家）

第 11 章拉丁美洲等温核酸扩增技术 (INAAT) 市场分析（依国家）

第十二章欧洲等温核酸扩增技术（INAAT）市场分析（依国家）

第十三章亚太地区等温核酸扩增技术 (INAAT) 市场分析（依国家）

第十四章中东与非洲等温核酸扩增技术 (INAAT) 市场分析

第十五章主要国家等温核酸扩增技术（INAAT）市场分析

  • 美国
  • 加拿大
  • 巴西
  • 墨西哥
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 中国
  • 日本
  • 韩国
  • 马来西亚
  • 新加坡
  • 澳大利亚
  • 纽西兰
  • 海湾合作委员会国家
  • 南非
  • 以色列

第十六章市场结构分析

  • 竞争对手仪表板
  • 竞争基准
  • 主要公司市占率分析

第十七章竞争分析

  • 衝突详情
    • Alere, Inc.
    • bioMerieux SA
    • Eiken Chemical Co. Ltd
    • Hologic Inc.（Gen-Probe）
    • Lucigen
    • Meridian Bioscience, Inc.
    • Ustar Biotechnologies Ltd.
    • QIAGEN
    • Quidel Corporation
    • Thermo Fisher Scientific, Inc.
    • BD（Becton, Dickinson &Company）

第 18 章先决条件与使用的缩写

第 19 章研究方法

简介目录
Product Code: PMRREP33206

Persistence Market Research presents an in-depth analysis of the Isothermal Nucleic Acid Amplification Technology (INAAT) Market, offering insights into its intricate dynamics and future trajectory. From market trends to growth catalysts, impediments, and emerging patterns, this report furnishes invaluable statistics and projections spanning from 2024 to 2033.

Key Insights:

  • INAAT Market Size (2024): USD 5.26 Billion
  • Projected Market Value (2033): USD 14.56 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 12.0%

INAAT Market - Report Scope:

The INAAT Market encompasses various applications across industries such as healthcare, pharmaceuticals, and biotechnology. INAAT is widely used for the rapid and accurate detection of nucleic acids, making it essential in disease diagnostics, pathogen detection, and genetic testing. This market caters to a wide range of end-users, including hospitals, diagnostic laboratories, research institutes, and biopharmaceutical companies, offering a versatile technology with numerous clinical and research applications. Market growth is driven by factors such as technological advancements, increasing demand for point-of-care diagnostics, and the rising prevalence of infectious diseases.

Market Growth Drivers:

The global INAAT Market is bolstered by several key growth drivers. Technological advancements in molecular diagnostics enhance the efficiency and applications of INAAT, driving its adoption across various industries. Moreover, the increasing demand for point-of-care diagnostics, especially in emerging economies, creates significant demand for INAAT as a key technology for rapid and accurate disease detection. Additionally, the growing emphasis on early and precise diagnosis of infectious diseases stimulates research and development activities, leading to the development of novel INAAT platforms and assays.

Market Restraints:

Despite its promising growth prospects, the INAAT Market faces challenges related to regulatory compliance, competition from alternative technologies, and high costs. Stringent regulatory requirements regarding diagnostic technologies impose compliance burdens on manufacturers and end-users, impacting market expansion. Furthermore, competition from other nucleic acid amplification technologies, such as PCR, poses challenges to the widespread adoption of INAAT. Additionally, the high costs associated with INAAT platforms and reagents can affect market growth, necessitating the development of cost-effective solutions.

Market Opportunities:

The INAAT Market presents lucrative growth opportunities driven by technological innovation, industry collaborations, and market diversification. Emerging trends such as personalized medicine, infectious disease outbreaks, and advancements in genetic research inspire manufacturers to explore new applications and formulations for INAAT in clinical and research settings. Moreover, strategic partnerships, research collaborations, and mergers and acquisitions enable market players to expand their product portfolios, enhance their technical capabilities, and strengthen their market presence in key regions. Furthermore, growing investments in research and development, coupled with increasing government support for innovation and healthcare infrastructure, create a conducive environment for market expansion and diversification.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the INAAT Market globally?
  • How are technological advancements and industry trends shaping the evolution of INAAT applications and formulations?
  • What are the key challenges and opportunities facing market participants in the INAAT segment?
  • Which industrial sectors and geographic regions offer the highest growth potential for INAAT manufacturers?
  • What strategies are leading companies employing to differentiate their INAAT offerings and capture market share in the competitive diagnostic landscape?

Competitive Intelligence and Business Strategy:

Leading players in the global INAAT Market, including diagnostic companies, pharmaceutical firms, and biotechnology enterprises, focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to develop advanced INAAT technologies, improve product quality, and explore new applications for INAAT in various industries. Moreover, strategic collaborations with research institutions, academic partners, and industry associations enable market players to access new technologies, expand their knowledge base, and accelerate product development efforts. Furthermore, emphasis on regulatory compliance, quality assurance, and customer support enhances brand reputation and fosters long-term relationships with customers and stakeholders.

Key Companies Profiled:

  • Alere, Inc.
  • bioMerieux SA
  • Eiken Chemical Co. Ltd
  • Hologic Inc.(Gen-Probe)
  • Lucigen
  • Meridian Bioscience, Inc.
  • Ustar Biotechnologies Ltd.
  • QIAGEN
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • BD (Becton, Dickinson & Company)
  • OptiGene Limited

INAAT Market Research Segmentation:

By Product Type

  • Instruments
  • Reagent

By Technology

  • NASBA
  • HDA
  • LAMP
  • SDA
  • SPIA
  • NEAR
  • TMA
  • RCA
  • RPA
  • SMAP2
  • Others

By Application

  • Blood Screening
  • Infectious Disease Diagnostics
  • Cancer
  • Others

By End User

  • Hospitals
  • Central & Reference Labs
  • Others

By Region

  • North America Market
  • Europe Market
  • Asia Pacific Market
  • Middle East & Africa Market
  • South America Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast, 2024-2033

  • 4.1. Historical Market Size Value (US$ Bn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2024-2033
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Bn) Analysis By Product , 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product , 2024-2033
    • 5.3.1. Instruments
    • 5.3.2. Reagent
  • 5.4. Y-o-Y Growth Trend Analysis By Product , 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product , 2024-2033

6. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Technology

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Bn) Analysis By Technology, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Technology, 2024-2033
    • 6.3.1. NASBA
    • 6.3.2. HAD
    • 6.3.3. LAMP
    • 6.3.4. SDA
    • 6.3.5. SPIA
    • 6.3.6. NEAR
    • 6.3.7. TMA
    • 6.3.8. RCA
    • 6.3.9. RPA
    • 6.3.10. SMAP2
    • 6.3.11. Others
  • 6.4. Y-o-Y Growth Trend Analysis By Technology, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Technology, 2024-2033

7. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Bn) Analysis By Application , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Application , 2024-2033
    • 7.3.1. Blood Screening
    • 7.3.2. Infectious Disease Diagnostics
    • 7.3.3. Cancer
    • 7.3.4. Others
  • 7.4. Y-o-Y Growth Trend Analysis By Application , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Application , 2024-2033

8. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By End-use

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size Value (US$ Bn) Analysis By End-use, 2019-2023
  • 8.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End-use, 2024-2033
    • 8.3.1. Hospitals
    • 8.3.2. Central & Reference Labs
    • 8.3.3. Others
  • 8.4. Y-o-Y Growth Trend Analysis By End-use, 2019-2023
  • 8.5. Absolute $ Opportunity Analysis By End-use, 2024-2033

9. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 9.1. Introduction
  • 9.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2019-2023
  • 9.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. Asia Pacific
    • 9.3.5. MEA
  • 9.4. Market Attractiveness Analysis By Region

10. North America Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 10.2.1. By Country
      • 10.2.1.1. U.S.
      • 10.2.1.2. Canada
    • 10.2.2. By Product
    • 10.2.3. By Technology
    • 10.2.4. By Application
    • 10.2.5. By End-use
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Technology
    • 10.3.4. By Application
    • 10.3.5. By End-use
  • 10.4. Key Takeaways

11. Latin America Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 11.2.1. By Country
      • 11.2.1.1. Brazil
      • 11.2.1.2. Mexico
      • 11.2.1.3. Rest of Latin America
    • 11.2.2. By Product
    • 11.2.3. By Technology
    • 11.2.4. By Application
    • 11.2.5. By End-use
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Technology
    • 11.3.4. By Application
    • 11.3.5. By End-use
  • 11.4. Key Takeaways

12. Europe Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 12.2.1. By Country
      • 12.2.1.1. Germany
      • 12.2.1.2. U.K.
      • 12.2.1.3. France
      • 12.2.1.4. Spain
      • 12.2.1.5. Italy
      • 12.2.1.6. Rest of Europe
    • 12.2.2. By Product
    • 12.2.3. By Technology
    • 12.2.4. By Application
    • 12.2.5. By End-use
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Technology
    • 12.3.4. By Application
    • 12.3.5. By End-use
  • 12.4. Key Takeaways

13. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 13.2.1. By Country
      • 13.2.1.1. China
      • 13.2.1.2. Japan
      • 13.2.1.3. South Korea
      • 13.2.1.4. India
      • 13.2.1.5. Malaysia
      • 13.2.1.6. Singapore
      • 13.2.1.7. Australia
      • 13.2.1.8. New Zealand
      • 13.2.1.9. Rest of APAC
    • 13.2.2. By Product
    • 13.2.3. By Technology
    • 13.2.4. By Application
    • 13.2.5. By End-use
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product
    • 13.3.3. By Technology
    • 13.3.4. By Application
    • 13.3.5. By End-use
  • 13.4. Key Takeaways

14. MEA Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 14.2.1. By Country
      • 14.2.1.1. GCC Countries
      • 14.2.1.2. South Africa
      • 14.2.1.3. Israel
      • 14.2.1.4. Rest of MEA
    • 14.2.2. By Product
    • 14.2.3. By Technology
    • 14.2.4. By Application
    • 14.2.5. By End-use
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product
    • 14.3.3. By Technology
    • 14.3.4. By Application
    • 14.3.5. By End-use
  • 14.4. Key Takeaways

15. Key Countries Isothermal Nucleic Acid Amplification Technology Market Analysis

  • 15.1. U.S.
    • 15.1.1. Pricing Analysis
    • 15.1.2. Market Share Analysis, 2024
      • 15.1.2.1. By Product
      • 15.1.2.2. By Technology
      • 15.1.2.3. By Application
      • 15.1.2.4. By End-use
  • 15.2. Canada
    • 15.2.1. Pricing Analysis
    • 15.2.2. Market Share Analysis, 2024
      • 15.2.2.1. By Product
      • 15.2.2.2. By Technology
      • 15.2.2.3. By Application
      • 15.2.2.4. By End-use
  • 15.3. Brazil
    • 15.3.1. Pricing Analysis
    • 15.3.2. Market Share Analysis, 2024
      • 15.3.2.1. By Product
      • 15.3.2.2. By Technology
      • 15.3.2.3. By Application
      • 15.3.2.4. By End-use
  • 15.4. Mexico
    • 15.4.1. Pricing Analysis
    • 15.4.2. Market Share Analysis, 2024
      • 15.4.2.1. By Product
      • 15.4.2.2. By Technology
      • 15.4.2.3. By Application
      • 15.4.2.4. By End-use
  • 15.5. Germany
    • 15.5.1. Pricing Analysis
    • 15.5.2. Market Share Analysis, 2024
      • 15.5.2.1. By Product
      • 15.5.2.2. By Technology
      • 15.5.2.3. By Application
      • 15.5.2.4. By End-use
  • 15.6. U.K.
    • 15.6.1. Pricing Analysis
    • 15.6.2. Market Share Analysis, 2024
      • 15.6.2.1. By Product
      • 15.6.2.2. By Technology
      • 15.6.2.3. By Application
      • 15.6.2.4. By End-use
  • 15.7. France
    • 15.7.1. Pricing Analysis
    • 15.7.2. Market Share Analysis, 2024
      • 15.7.2.1. By Product
      • 15.7.2.2. By Technology
      • 15.7.2.3. By Application
      • 15.7.2.4. By End-use
  • 15.8. Spain
    • 15.8.1. Pricing Analysis
    • 15.8.2. Market Share Analysis, 2024
      • 15.8.2.1. By Product
      • 15.8.2.2. By Technology
      • 15.8.2.3. By Application
      • 15.8.2.4. By End-use
  • 15.9. Italy
    • 15.9.1. Pricing Analysis
    • 15.9.2. Market Share Analysis, 2024
      • 15.9.2.1. By Product
      • 15.9.2.2. By Technology
      • 15.9.2.3. By Application
      • 15.9.2.4. By End-use
  • 15.10. China
    • 15.10.1. Pricing Analysis
    • 15.10.2. Market Share Analysis, 2024
      • 15.10.2.1. By Product
      • 15.10.2.2. By Technology
      • 15.10.2.3. By Application
      • 15.10.2.4. By End-use
  • 15.11. Japan
    • 15.11.1. Pricing Analysis
    • 15.11.2. Market Share Analysis, 2024
      • 15.11.2.1. By Product
      • 15.11.2.2. By Technology
      • 15.11.2.3. By Application
      • 15.11.2.4. By End-use
  • 15.12. South Korea
    • 15.12.1. Pricing Analysis
    • 15.12.2. Market Share Analysis, 2024
      • 15.12.2.1. By Product
      • 15.12.2.2. By Technology
      • 15.12.2.3. By Application
      • 15.12.2.4. By End-use
  • 15.13. Malaysia
    • 15.13.1. Pricing Analysis
    • 15.13.2. Market Share Analysis, 2024
      • 15.13.2.1. By Product
      • 15.13.2.2. By Technology
      • 15.13.2.3. By Application
      • 15.13.2.4. By End-use
  • 15.14. Singapore
    • 15.14.1. Pricing Analysis
    • 15.14.2. Market Share Analysis, 2024
      • 15.14.2.1. By Product
      • 15.14.2.2. By Technology
      • 15.14.2.3. By Application
      • 15.14.2.4. By End-use
  • 15.15. Australia
    • 15.15.1. Pricing Analysis
    • 15.15.2. Market Share Analysis, 2024
      • 15.15.2.1. By Product
      • 15.15.2.2. By Technology
      • 15.15.2.3. By Application
      • 15.15.2.4. By End-use
  • 15.16. New Zealand
    • 15.16.1. Pricing Analysis
    • 15.16.2. Market Share Analysis, 2024
      • 15.16.2.1. By Product
      • 15.16.2.2. By Technology
      • 15.16.2.3. By Application
      • 15.16.2.4. By End-use
  • 15.17. GCC Countries
    • 15.17.1. Pricing Analysis
    • 15.17.2. Market Share Analysis, 2024
      • 15.17.2.1. By Product
      • 15.17.2.2. By Technology
      • 15.17.2.3. By Application
      • 15.17.2.4. By End-use
  • 15.18. South Africa
    • 15.18.1. Pricing Analysis
    • 15.18.2. Market Share Analysis, 2024
      • 15.18.2.1. By Product
      • 15.18.2.2. By Technology
      • 15.18.2.3. By Application
      • 15.18.2.4. By End-use
  • 15.19. Israel
    • 15.19.1. Pricing Analysis
    • 15.19.2. Market Share Analysis, 2024
      • 15.19.2.1. By Product
      • 15.19.2.2. By Technology
      • 15.19.2.3. By Application
      • 15.19.2.4. By End-use

16. Market Structure Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Benchmarking
  • 16.3. Market Share Analysis of Top Players
    • 16.3.1. By Regional
    • 16.3.2. By Product
    • 16.3.3. By Technology
    • 16.3.4. By Application
    • 16.3.5. By End-use

17. Competition Analysis

  • 17.1. Competition Deep Dive
    • 17.1.1. Alere, Inc.
      • 17.1.1.1. Overview
      • 17.1.1.2. Product Portfolio
      • 17.1.1.3. Profitability by Market Segments
      • 17.1.1.4. Sales Footprint
      • 17.1.1.5. Strategy Overview
        • 17.1.1.5.1. Marketing Strategy
    • 17.1.2. bioMerieux SA
      • 17.1.2.1. Overview
      • 17.1.2.2. Product Portfolio
      • 17.1.2.3. Profitability by Market Segments
      • 17.1.2.4. Sales Footprint
      • 17.1.2.5. Strategy Overview
        • 17.1.2.5.1. Marketing Strategy
    • 17.1.3. Eiken Chemical Co. Ltd
      • 17.1.3.1. Overview
      • 17.1.3.2. Product Portfolio
      • 17.1.3.3. Profitability by Market Segments
      • 17.1.3.4. Sales Footprint
      • 17.1.3.5. Strategy Overview
        • 17.1.3.5.1. Marketing Strategy
    • 17.1.4. Hologic Inc.(Gen-Probe)
      • 17.1.4.1. Overview
      • 17.1.4.2. Product Portfolio
      • 17.1.4.3. Profitability by Market Segments
      • 17.1.4.4. Sales Footprint
      • 17.1.4.5. Strategy Overview
        • 17.1.4.5.1. Marketing Strategy
    • 17.1.5. Lucigen
      • 17.1.5.1. Overview
      • 17.1.5.2. Product Portfolio
      • 17.1.5.3. Profitability by Market Segments
      • 17.1.5.4. Sales Footprint
      • 17.1.5.5. Strategy Overview
        • 17.1.5.5.1. Marketing Strategy
    • 17.1.6. Meridian Bioscience, Inc.
      • 17.1.6.1. Overview
      • 17.1.6.2. Product Portfolio
      • 17.1.6.3. Profitability by Market Segments
      • 17.1.6.4. Sales Footprint
      • 17.1.6.5. Strategy Overview
        • 17.1.6.5.1. Marketing Strategy
    • 17.1.7. Ustar Biotechnologies Ltd.
      • 17.1.7.1. Overview
      • 17.1.7.2. Product Portfolio
      • 17.1.7.3. Profitability by Market Segments
      • 17.1.7.4. Sales Footprint
      • 17.1.7.5. Strategy Overview
        • 17.1.7.5.1. Marketing Strategy
    • 17.1.8. QIAGEN
      • 17.1.8.1. Overview
      • 17.1.8.2. Product Portfolio
      • 17.1.8.3. Profitability by Market Segments
      • 17.1.8.4. Sales Footprint
      • 17.1.8.5. Strategy Overview
        • 17.1.8.5.1. Marketing Strategy
    • 17.1.9. Quidel Corporation
      • 17.1.9.1. Overview
      • 17.1.9.2. Product Portfolio
      • 17.1.9.3. Profitability by Market Segments
      • 17.1.9.4. Sales Footprint
      • 17.1.9.5. Strategy Overview
        • 17.1.9.5.1. Marketing Strategy
    • 17.1.10. Thermo Fisher Scientific, Inc.
      • 17.1.10.1. Overview
      • 17.1.10.2. Product Portfolio
      • 17.1.10.3. Profitability by Market Segments
      • 17.1.10.4. Sales Footprint
      • 17.1.10.5. Strategy Overview
        • 17.1.10.5.1. Marketing Strategy
    • 17.1.11. BD (Becton, Dickinson & Company)
      • 17.1.11.1. Overview
      • 17.1.11.2. Product Portfolio
      • 17.1.11.3. Profitability by Market Segments
      • 17.1.11.4. Sales Footprint
      • 17.1.11.5. Strategy Overview
        • 17.1.11.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology